BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsuzuno T, Takahashi N, Yamada-Hara M, Yokoji-Takeuchi M, Sulijaya B, Aoki-Nonaka Y, Matsugishi A, Katakura K, Tabeta K, Yamazaki K. Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice. J Periodontal Res 2021;56:275-88. [PMID: 33512709 DOI: 10.1111/jre.12816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Nonaka S, Kadowaki T, Nakanishi H. Secreted gingipains from Porphyromonas gingivalis increase permeability in human cerebral microvascular endothelial cells through intracellular degradation of tight junction proteins. Neurochem Int 2022;:105282. [PMID: 35032577 DOI: 10.1016/j.neuint.2022.105282] [Reference Citation Analysis]
2 Yu M, Li Z, Rong T, Tian Z, Deng D, Lu H, Zhang R, Ma X. Integrated metagenomics-metabolomics analysis reveals the cecal microbial composition, function, and metabolites of pigs fed diets with different starch sources. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.110951] [Reference Citation Analysis]
3 Jin S, Wetzel D, Schirmer M. Deciphering mechanisms and implications of bacterial translocation in human health and disease. Curr Opin Microbiol 2022;67:102147. [PMID: 35461008 DOI: 10.1016/j.mib.2022.102147] [Reference Citation Analysis]
4 Madsen GR, Bertl K, Pandis N, Stavropoulos A, Burisch J. The Impact of Periodontitis on Inflammatory Bowel Disease Activity. Inflamm Bowel Dis 2022:izac090. [PMID: 35552410 DOI: 10.1093/ibd/izac090] [Reference Citation Analysis]
5 Cai Z, Zhu T, Liu F, Zhuang Z, Zhao L. Co-pathogens in Periodontitis and Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:723719. [PMID: 34616755 DOI: 10.3389/fmed.2021.723719] [Reference Citation Analysis]
6 Qian J, Lu J, Huang Y, Wang M, Chen B, Bao J, Wang L, Cui D, Luo B, Yan F. Periodontitis Salivary Microbiota Worsens Colitis. J Dent Res 2021;:220345211049781. [PMID: 34796773 DOI: 10.1177/00220345211049781] [Reference Citation Analysis]
7 Chi L, Cheng X, Lin L, Yang T, Sun J, Feng Y, Liang F, Pei Z, Teng W. Porphyromonas gingivalis-Induced Cognitive Impairment Is Associated With Gut Dysbiosis, Neuroinflammation, and Glymphatic Dysfunction. Front Cell Infect Microbiol 2021;11:755925. [PMID: 34926316 DOI: 10.3389/fcimb.2021.755925] [Reference Citation Analysis]
8 Dong Z, Lv W, Zhang C, Chen S. Correlation Analysis of Gut Microbiota and Serum Metabolome With Porphyromonas gingivalis-Induced Metabolic Disorders. Front Cell Infect Microbiol 2022;12:858902. [DOI: 10.3389/fcimb.2022.858902] [Reference Citation Analysis]
9 Karaçam S, Tunçer S. Exploiting the Acidic Extracellular pH: Evaluation of Streptococcus salivarius M18 Postbiotics to Target Cancer Cells. Probiotics Antimicrob Proteins 2021. [PMID: 34080175 DOI: 10.1007/s12602-021-09806-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wang T, Ishikawa T, Sasaki M, Chiba T. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis. Front Med (Lausanne) 2022;9:822190. [PMID: 35308549 DOI: 10.3389/fmed.2022.822190] [Reference Citation Analysis]
11 Liu Y, Huang W, Wang J, Ma J, Zhang M, Lu X, Liu J, Kou Y. Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier. Front Immunol 2021;12:693479. [PMID: 34386004 DOI: 10.3389/fimmu.2021.693479] [Reference Citation Analysis]
12 Imai J, Kitamoto S, Kamada N. The pathogenic oral-gut-liver axis: new understandings and clinical implications. Expert Rev Clin Immunol 2021;17:727-36. [PMID: 34057877 DOI: 10.1080/1744666X.2021.1935877] [Reference Citation Analysis]